https://www.selleckchem.com/CDK.html
To examine the rate of ovulatory disruption when intramuscular depot medroxyprogesterone acetate (DMPA) is administered across graded stages of dominant follicle development. We assigned enrolled participants to one of three preassigned dominant follicle size groups 12-14 mm, 15-17 mm and ≥18 mm. We followed dominant follicles via serial transvaginal ultrasound (TVUS) until the follicles reached their assigned size, at which time we administered DMPA. For 5 consecutive days thereafter, we followed the follicles via TVUS to observe follicle rupture a
إعجاب
علق
شارك
